Céline Chapelle Shares Clinical Predictors From the API-CAT Trial
Céline Chapelle, Biostatistician at CHU Saint-Étienne, shared on LinkedIn:
“Very happy to share our latest publication in Lancet Haematology.
“Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial”
In this post-hoc analysis of the API-CAT study, including patients with cancer-associated thromosis (CAT) receiving extended anticoagulant with apixaban: – Four clinical predictors were significantly associated with an increased risk of clinically relevant bleeding: anaemia and/or thrombocytopenia, age ≥75, pulmonary embolism as the index event, and male sex.
Three of them were also significant predictors of major bleeding.
Many thanks to all co-authors and collaborators for this excellent teamwork.”
Read the full article here.
Article: Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Authors: Isabelle Mahé, Céline Chapellee, Philippe Girard, Marc Carrier, Luis Jara Palomares, Charles-Marc Samama, Hélène Helfer, Prof Grigoris Gerotziafas, Silvy Laporte, Eric Vicaut, Patrick Mismetti
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025